A drug called resmetirom (Rezdiffra) has also been FDA approved to treat adults with MASH who have moderate to advanced liver scarring
Headaches that do not respond to hydration
Dosing Flexibility: While autoinjectors typically deliver a fixed dose, the ongoing development of variable-dose autoinjector platforms and smart, connected pens is setting the stage for more personalized treatment regimens
Perfect Bars bring together whole food protein and 20+ superfoods in a convenient bar
B12 works to metabolize homocysteine, an amino acid that at elevated levels is a well-established independent risk factor for heart disease and stroke
NovoCare self-pay program Novo Nordisk's NovoCare program offers a self-pay price of approximately $199 per month for the starting doses (0.25/0.5 mg, first two fills through December 31, 2026), then approximately $349 per month for standard injection doses